APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxycarbamide

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

Selected research

Industry Growth & Trends

Global Hydroxycarbamide Industry Growth and Trends Forecast to 2032

21 December 2025102 pages

Choose your research edition.

Industry ResearchHydroxycarbamide Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxycarbamide Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Hydroxycarbamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxycarbamide Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxycarbamide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

Global Hydroxycarbamide key players include Qilu Pharmaceutical, Beijing Jialin Pharma, Taj Pharma, etc. Global top three manufacturers hold a share over 35%.

Read the full market overview

Asia-Pacific is the largest market, with a share nearly 60%, followed by Europe, and North America, both have a share about 40 percent.

In terms of product, Capsule is the largest segment, with a share over 60%. And in terms of application, the largest application is Sickle Cell Disease, followed by Cancer, etc.

Report Scope

This report provides a structured, data-driven view of the global Hydroxycarbamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydroxycarbamide market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxycarbamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxycarbamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydroxycarbamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydroxycarbamide Market by Company

Bristol Myers Squibb

Taj Pharma

Beijing Jialin Pharma

Qilu Pharmaceutical

Teva Pharma

Cipla

Zydus Cadila

United Biotech

Par Pharma

Khandelwal Laboratories

Alkem (Cytomed)

Samarth Pharma

VHB Life Sciences

Hydroxycarbamide Segment by Type

Capsule

Tablet

Hydroxycarbamide Segment by Application

Sickle Cell Disease

Cancer

Others

Hydroxycarbamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxycarbamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxycarbamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxycarbamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxycarbamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydroxycarbamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Tablet Table 3. Global Hydroxycarbamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 5. Global Hydroxycarbamide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hydroxycarbamide Sales Market Share in Value by Type (2021-2026) Table 8. Global Hydroxycarbamide Price by Type (2021-2026) & (USD/K Unit) Table 9. Global Hydroxycarbamide Sales by Type (2027-2032) & (M Units) Table 10. Global Hydroxycarbamide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hydroxycarbamide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hydroxycarbamide Sales Market Share in Value by Type (2027-2032) Table 13. Global Hydroxycarbamide Price by Type (2027-2032) & (USD/K Unit) Table 14. North America Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 15. North America Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 17. Europe Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 21. Latin America Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hydroxycarbamide Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Hydroxycarbamide Sales by Type (2021-2026) & (US$ Million) Table 24. Hydroxycarbamide Industry Trends Table 25. Hydroxycarbamide Industry Drivers Table 26. Hydroxycarbamide Industry Opportunities and Challenges Table 27. Hydroxycarbamide Industry Restraints Table 28. Global Hydroxycarbamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hydroxycarbamide Revenue Market Share by Company (2021-2026) Table 30. Global Hydroxycarbamide Sales by Company (2021-2026) & (M Units) Table 31. Global Hydroxycarbamide Sales Share by Company (2021-2026) Table 32. Global Hydroxycarbamide Market Price by Company (2021-2026) & (USD/K Unit) Table 33. Global Hydroxycarbamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hydroxycarbamide Major Company Production Sites and Headquarters Table 35. Global Hydroxycarbamide Company, Product Type & Application Table 36. Global Hydroxycarbamide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hydroxycarbamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hydroxycarbamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hydroxycarbamide Sales by Region (2021-2026) & (M Units) Table 41. Global Hydroxycarbamide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hydroxycarbamide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hydroxycarbamide Sales Market Share in Value by Region (2021-2026) Table 44. Global Hydroxycarbamide Sales (M Units), Value (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 45. Global Hydroxycarbamide Sales by Region (2027-2032) & (M Units) Table 46. Global Hydroxycarbamide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hydroxycarbamide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hydroxycarbamide Sales Market Share in Value by Region (2027-2032) Table 49. Global Hydroxycarbamide Sales (M Units), Value (US$ Million), Price (USD/K Unit) and Gross Margin (2027-2032) Table 50. Global Hydroxycarbamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 52. Global Hydroxycarbamide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hydroxycarbamide Sales Market Share in Value by Application (2021-2026) Table 55. Global Hydroxycarbamide Price by Application (2021-2026) & (USD/K Unit) Table 56. Global Hydroxycarbamide Sales by Application (2027-2032) & (M Units) Table 57. Global Hydroxycarbamide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hydroxycarbamide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hydroxycarbamide Sales Market Share in Value by Application (2027-2032) Table 60. Global Hydroxycarbamide Price by Application (2027-2032) & (USD/K Unit) Table 61. North America Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 62. North America Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 64. Europe Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 68. Latin America Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hydroxycarbamide Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Hydroxycarbamide Sales by Application (2021-2026) & (US$ Million) Table 71. Bristol Myers Squibb Company Information Table 72. Bristol Myers Squibb Business Overview Table 73. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 74. Bristol Myers Squibb Hydroxycarbamide Product Portfolio Table 75. Bristol Myers Squibb Recent Development Table 76. Taj Pharma Company Information Table 77. Taj Pharma Business Overview Table 78. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 79. Taj Pharma Hydroxycarbamide Product Portfolio Table 80. Taj Pharma Recent Development Table 81. Beijing Jialin Pharma Company Information Table 82. Beijing Jialin Pharma Business Overview Table 83. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 84. Beijing Jialin Pharma Hydroxycarbamide Product Portfolio Table 85. Beijing Jialin Pharma Recent Development Table 86. Qilu Pharmaceutical Company Information Table 87. Qilu Pharmaceutical Business Overview Table 88. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 89. Qilu Pharmaceutical Hydroxycarbamide Product Portfolio Table 90. Qilu Pharmaceutical Recent Development Table 91. Teva Pharma Company Information Table 92. Teva Pharma Business Overview Table 93. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 94. Teva Pharma Hydroxycarbamide Product Portfolio Table 95. Teva Pharma Recent Development Table 96. Cipla Company Information Table 97. Cipla Business Overview Table 98. Cipla Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 99. Cipla Hydroxycarbamide Product Portfolio Table 100. Cipla Recent Development Table 101. Zydus Cadila Company Information Table 102. Zydus Cadila Business Overview Table 103. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 104. Zydus Cadila Hydroxycarbamide Product Portfolio Table 105. Zydus Cadila Recent Development Table 106. United Biotech Company Information Table 107. United Biotech Business Overview Table 108. United Biotech Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 109. United Biotech Hydroxycarbamide Product Portfolio Table 110. United Biotech Recent Development Table 111. Par Pharma Company Information Table 112. Par Pharma Business Overview Table 113. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 114. Par Pharma Hydroxycarbamide Product Portfolio Table 115. Par Pharma Recent Development Table 116. Khandelwal Laboratories Company Information Table 117. Khandelwal Laboratories Business Overview Table 118. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 119. Khandelwal Laboratories Hydroxycarbamide Product Portfolio Table 120. Khandelwal Laboratories Recent Development Table 121. Alkem (Cytomed) Company Information Table 122. Alkem (Cytomed) Business Overview Table 123. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 124. Alkem (Cytomed) Hydroxycarbamide Product Portfolio Table 125. Alkem (Cytomed) Recent Development Table 126. Samarth Pharma Company Information Table 127. Samarth Pharma Business Overview Table 128. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 129. Samarth Pharma Hydroxycarbamide Product Portfolio Table 130. Samarth Pharma Recent Development Table 131. VHB Life Sciences Company Information Table 132. VHB Life Sciences Business Overview Table 133. VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2021-2026) Table 134. VHB Life Sciences Hydroxycarbamide Product Portfolio Table 135. VHB Life Sciences Recent Development Table 136. North America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 137. North America Hydroxycarbamide Sales by Country (2021-2026) & (M Units) Table 138. North America Hydroxycarbamide Sales Market Share by Country (2021-2026) Table 139. North America Hydroxycarbamide Sales Forecast by Country (2027-2032) & (M Units) Table 140. North America Hydroxycarbamide Sales Market Share Forecast by Country (2027-2032) Table 141. North America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Hydroxycarbamide Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Hydroxycarbamide Market Share by Country (2021-2026) Table 144. North America Hydroxycarbamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Hydroxycarbamide Market Share Forecast by Country (2027-2032) Table 146. Europe Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 147. Europe Hydroxycarbamide Sales by Country (2021-2026) & (M Units) Table 148. Europe Hydroxycarbamide Sales Market Share by Country (2021-2026) Table 149. Europe Hydroxycarbamide Sales Forecast by Country (2027-2032) & (M Units) Table 150. Europe Hydroxycarbamide Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Hydroxycarbamide Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Hydroxycarbamide Market Share by Country (2021-2026) Table 154. Europe Hydroxycarbamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Hydroxycarbamide Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Hydroxycarbamide Sales by Country (2021-2026) & (M Units) Table 158. Asia-Pacific Hydroxycarbamide Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Hydroxycarbamide Sales Forecast by Country (2027-2032) & (M Units) Table 160. Asia-Pacific Hydroxycarbamide Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Hydroxycarbamide Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Hydroxycarbamide Market Share by Country (2021-2026) Table 164. Asia-Pacific Hydroxycarbamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Hydroxycarbamide Market Share Forecast by Country (2027-2032) Table 166. Latin America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 167. Latin America Hydroxycarbamide Sales by Country (2021-2026) & (M Units) Table 168. Latin America Hydroxycarbamide Sales Market Share by Country (2021-2026) Table 169. Latin America Hydroxycarbamide Sales Forecast by Country (2027-2032) & (M Units) Table 170. Latin America Hydroxycarbamide Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Hydroxycarbamide Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Hydroxycarbamide Market Share by Country (2021-2026) Table 174. Latin America Hydroxycarbamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Hydroxycarbamide Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Hydroxycarbamide Sales by Country (2021-2026) & (M Units) Table 178. Middle East and Africa Hydroxycarbamide Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Hydroxycarbamide Sales Forecast by Country (2027-2032) & (M Units) Table 180. Middle East and Africa Hydroxycarbamide Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Hydroxycarbamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Hydroxycarbamide Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Hydroxycarbamide Market Share by Country (2021-2026) Table 184. Middle East and Africa Hydroxycarbamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Hydroxycarbamide Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Hydroxycarbamide Distributors List Table 189. Hydroxycarbamide Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Hydroxycarbamide Image Figure 2. Global Hydroxycarbamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxycarbamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxycarbamide Sales (2021-2032) & (M Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (M Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Hydroxycarbamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hydroxycarbamide Market Share by Type 2025 VS 2032 Figure 11. North America Hydroxycarbamide Sales Market Share in Volume by Type in 2025 Figure 12. North America Hydroxycarbamide Sales Market Share in Value by Type in 2025 Figure 13. Europe Hydroxycarbamide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hydroxycarbamide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hydroxycarbamide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hydroxycarbamide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hydroxycarbamide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hydroxycarbamide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hydroxycarbamide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hydroxycarbamide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hydroxycarbamide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Sickle Cell Disease Image Figure 24. Global Sickle Cell Disease Sales YoY Growth (2021-2032) & (M Units) Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (M Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Hydroxycarbamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Hydroxycarbamide Market Share by Application 2025 VS 2032 Figure 31. North America Hydroxycarbamide Sales Market Share in Volume by Application in 2025 Figure 32. North America Hydroxycarbamide Sales Market Share in Value by Application in 2025 Figure 33. Europe Hydroxycarbamide Sales Market Share in Volume by Application in 2025 Figure 34. Europe Hydroxycarbamide Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Hydroxycarbamide Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Hydroxycarbamide Sales Market Share in Value by Application in 2025 Figure 37. Latin America Hydroxycarbamide Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Hydroxycarbamide Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Hydroxycarbamide Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Hydroxycarbamide Sales Market Share in Value by Application in 2025 Figure 41. North America Hydroxycarbamide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Hydroxycarbamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Hydroxycarbamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Hydroxycarbamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hydroxycarbamide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Hydroxycarbamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hydroxycarbamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Hydroxycarbamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hydroxycarbamide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Hydroxycarbamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hydroxycarbamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Hydroxycarbamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hydroxycarbamide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Hydroxycarbamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hydroxycarbamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Hydroxycarbamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hydroxycarbamide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Hydroxycarbamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hydroxycarbamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Hydroxycarbamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Hydroxycarbamide Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Hydroxycarbamide Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
Applications
  • Sickle Cell Disease
  • Cancer
  • Others
Companies covered
  • Bristol Myers Squibb
  • Taj Pharma
  • Beijing Jialin Pharma
  • Qilu Pharmaceutical
  • Teva Pharma
  • Cipla
  • Zydus Cadila
  • United Biotech
  • Par Pharma
  • Khandelwal Laboratories
  • Alkem (Cytomed)
  • Samarth Pharma
  • VHB Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxycarbamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydroxycarbamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydroxycarbamide Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Tablet
  8. 1.4 Global Hydroxycarbamide Market Size by Type
  9. 1.4.1 Global Hydroxycarbamide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hydroxycarbamide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hydroxycarbamide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hydroxycarbamide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hydroxycarbamide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hydroxycarbamide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hydroxycarbamide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hydroxycarbamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydroxycarbamide Industry Trends
  2. 2.2 Hydroxycarbamide Industry Drivers
  3. 2.3 Hydroxycarbamide Industry Opportunities and Challenges
  4. 2.4 Hydroxycarbamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydroxycarbamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydroxycarbamide Sales (2021-2026)
  3. 3.3 Global Top Players by Hydroxycarbamide Price (2021-2026)
  4. 3.4 Global Hydroxycarbamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxycarbamide Major Company Production Sites & Headquarters
  6. 3.6 Global Hydroxycarbamide Company, Product Type & Application
  7. 3.7 Global Hydroxycarbamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxycarbamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxycarbamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxycarbamide Tier 1, Tier 2, and Tier 3
4 Hydroxycarbamide Regional Status and Outlook
  1. 4.1 Global Hydroxycarbamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydroxycarbamide Historic Market Size by Region
  3. 4.2.1 Global Hydroxycarbamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydroxycarbamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydroxycarbamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydroxycarbamide Forecasted Market Size by Region
  7. 4.3.1 Global Hydroxycarbamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydroxycarbamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydroxycarbamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxycarbamide by Application
  1. 5.1 Hydroxycarbamide Market by Application
  2. 5.1.1 Sickle Cell Disease
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Hydroxycarbamide Market Size by Application
  6. 5.2.1 Global Hydroxycarbamide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hydroxycarbamide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hydroxycarbamide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hydroxycarbamide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hydroxycarbamide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hydroxycarbamide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hydroxycarbamide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hydroxycarbamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol Myers Squibb
  2. 6.1.1 Bristol Myers Squibb Company Information
  3. 6.1.2 Bristol Myers Squibb Business Overview
  4. 6.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol Myers Squibb Hydroxycarbamide Product Portfolio
  6. 6.1.5 Bristol Myers Squibb Recent Developments
  7. 6.2 Taj Pharma
  8. 6.2.1 Taj Pharma Company Information
  9. 6.2.2 Taj Pharma Business Overview
  10. 6.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taj Pharma Hydroxycarbamide Product Portfolio
  12. 6.2.5 Taj Pharma Recent Developments
  13. 6.3 Beijing Jialin Pharma
  14. 6.3.1 Beijing Jialin Pharma Company Information
  15. 6.3.2 Beijing Jialin Pharma Business Overview
  16. 6.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beijing Jialin Pharma Hydroxycarbamide Product Portfolio
  18. 6.3.5 Beijing Jialin Pharma Recent Developments
  19. 6.4 Qilu Pharmaceutical
  20. 6.4.1 Qilu Pharmaceutical Company Information
  21. 6.4.2 Qilu Pharmaceutical Business Overview
  22. 6.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Qilu Pharmaceutical Hydroxycarbamide Product Portfolio
  24. 6.4.5 Qilu Pharmaceutical Recent Developments
  25. 6.5 Teva Pharma
  26. 6.5.1 Teva Pharma Company Information
  27. 6.5.2 Teva Pharma Business Overview
  28. 6.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharma Hydroxycarbamide Product Portfolio
  30. 6.5.5 Teva Pharma Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Hydroxycarbamide Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Zydus Cadila
  38. 6.7.1 Zydus Cadila Company Information
  39. 6.7.2 Zydus Cadila Business Overview
  40. 6.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus Cadila Hydroxycarbamide Product Portfolio
  42. 6.7.5 Zydus Cadila Recent Developments
  43. 6.8 United Biotech
  44. 6.8.1 United Biotech Company Information
  45. 6.8.2 United Biotech Business Overview
  46. 6.8.3 United Biotech Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 United Biotech Hydroxycarbamide Product Portfolio
  48. 6.8.5 United Biotech Recent Developments
  49. 6.9 Par Pharma
  50. 6.9.1 Par Pharma Company Information
  51. 6.9.2 Par Pharma Business Overview
  52. 6.9.3 Par Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Par Pharma Hydroxycarbamide Product Portfolio
  54. 6.9.5 Par Pharma Recent Developments
  55. 6.10 Khandelwal Laboratories
  56. 6.10.1 Khandelwal Laboratories Company Information
  57. 6.10.2 Khandelwal Laboratories Business Overview
  58. 6.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Khandelwal Laboratories Hydroxycarbamide Product Portfolio
  60. 6.10.5 Khandelwal Laboratories Recent Developments
  61. 6.11 Alkem (Cytomed)
  62. 6.11.1 Alkem (Cytomed) Company Information
  63. 6.11.2 Alkem (Cytomed) Business Overview
  64. 6.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Alkem (Cytomed) Hydroxycarbamide Product Portfolio
  66. 6.11.5 Alkem (Cytomed) Recent Developments
  67. 6.12 Samarth Pharma
  68. 6.12.1 Samarth Pharma Company Information
  69. 6.12.2 Samarth Pharma Business Overview
  70. 6.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Samarth Pharma Hydroxycarbamide Product Portfolio
  72. 6.12.5 Samarth Pharma Recent Developments
  73. 6.13 VHB Life Sciences
  74. 6.13.1 VHB Life Sciences Company Information
  75. 6.13.2 VHB Life Sciences Business Overview
  76. 6.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 VHB Life Sciences Hydroxycarbamide Product Portfolio
  78. 6.13.5 VHB Life Sciences Recent Developments
7 North America by Country
  1. 7.1 North America Hydroxycarbamide Sales by Country
  2. 7.1.1 North America Hydroxycarbamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydroxycarbamide Sales by Country (2021-2026)
  4. 7.1.3 North America Hydroxycarbamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydroxycarbamide Market Size by Country
  6. 7.2.1 North America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydroxycarbamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydroxycarbamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydroxycarbamide Sales by Country
  2. 8.1.1 Europe Hydroxycarbamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydroxycarbamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydroxycarbamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydroxycarbamide Market Size by Country
  6. 8.2.1 Europe Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydroxycarbamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydroxycarbamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydroxycarbamide Sales by Country
  2. 9.1.1 Asia-Pacific Hydroxycarbamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydroxycarbamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydroxycarbamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydroxycarbamide Market Size by Country
  6. 9.2.1 Asia-Pacific Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydroxycarbamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydroxycarbamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydroxycarbamide Sales by Country
  2. 10.1.1 South America Hydroxycarbamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydroxycarbamide Sales by Country (2021-2026)
  4. 10.1.3 South America Hydroxycarbamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydroxycarbamide Market Size by Country
  6. 10.2.1 South America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydroxycarbamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydroxycarbamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydroxycarbamide Sales by Country
  2. 11.1.1 Middle East and Africa Hydroxycarbamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydroxycarbamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydroxycarbamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydroxycarbamide Market Size by Country
  6. 11.2.1 Middle East and Africa Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydroxycarbamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydroxycarbamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydroxycarbamide Value Chain Analysis
  2. 12.1.1 Hydroxycarbamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydroxycarbamide Production Mode & Process
  7. 12.2 Hydroxycarbamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydroxycarbamide Distributors
  10. 12.2.3 Hydroxycarbamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst